丙肝患者药物相关性不良反应及护理干预的研究进展

Research progress of drug-related adverse reactions in hepatitis C patients and related nursing interventions

聚乙二醇干扰素(PEG-IFN)联合利巴韦林(RBV)的方案和直接抗病毒药物(DAA)是目前临床较为常见丙型病毒性肝炎治疗方案。本文对两种治疗方案的不良反应及护理干预进行综述,旨在引起医护人员和患者对不良反应的关注及再认识,为医护人员提供全维度的护理干预措施提供参考。

Combination of peginterferon-alpha(PEG-IFN)and ribavirin(RBV)therapy is the current standard of care for chronic hepatitis C.This paper reviewed the studies of drug-related adverse reactions in hepatitis C patients who received PEG-IFN and RBV therapy,in order to in⁃crease awareness of medical staff and patients on drug-related adverse reactions,and provide refer⁃ence for implementation of comprehensive interventions.